Star Combo Pharma (ASX:S66) sucessfully listed on ASX
Star Combo Pharma Limited (ASX: S66) was successfully launch its initial public offering at ASX on 16th May 2018. Underwritten by FG Synergy, Star Combo saw the public portion of its IPO oversubscribed by two times. The IPO immediately became a blockbuster among investors and its price skyrocketed more than sixfold in the first week.
business that develops, manufactures and distributes a range of branded vitamins, dietary supplements and skincare products, serving both domestic and growing offshore markets (mainly Asian countries). The Company is one of nine TGA soft gel production licence holders in Australia. It provides OEM facilities to other vitamin companies, and owns six brands - Costar, Amax, Kainan, Green Health Food, J&K and Living Healthy. Star Combo is headquartered in Sydney, Australia and has on-the-ground presence in Smithfield, New South Wales. Within Australia, the Company’s products are sold in pharmacies, souvenir / convenience / grocery stores, gyms, petrol stations as well as pop up stands in the Sydney International Airport. Internationally, Star Combo sells its products internationally through its own website as well as various online sales platforms (Taobao, J D etc). The Company has also focused on distributing its products into pharmacies, souvenir stores and retail shops.
Star Combo’s TGA license allows the Company to manufacture a wide range of therapeutic goods such as powder, tablet, hard capsule and soft gel products. The license also grants Star Combo the ability to manufacture products for both its own brands and other companies in the industry, providing they fall within the stipulated types of therapeutic goods.